Tag: Liver Disease
-
NUH and Siemens Expand Ultrasound Tech to Revolutionize Liver Disease Diagnostics
NUH and Siemens Partner to Advance Ultrasound-Based Liver Diagnostics Hospitals in Singapore’s healthcare landscape are witnessing a significant collaboration as National University Hospital (NUH) teams up with Siemens Healthineers to study and develop next-generation ultrasound technologies focused on liver disease diagnostics. This partnership underscores a broader push toward non-invasive, accurate, and accessible liver imaging that…
-
NT Leads Australia in Hepatitis B Care as Diagnoses Rise and Mortality Falls
NT Becomes national leader in hepatitis B care as diagnoses rise, mortality falls In the Northern Territory, a striking story is unfolding. Rather than signaling a crisis, a surge in hepatitis B diagnoses is being read by health workers as a sign of stronger, more accessible care. The territory has become a benchmark in Australia…
-
CORE Model: Simple Blood Tests Predict Liver Disease Risk
What is the CORE model? A new tool, the CORE model, is being developed to help primary care teams assess the risk of serious liver diseases. The aim is to identify patients who are at higher risk of conditions such as cirrhosis, liver cancer, or the potential need for a liver transplant within the next…
-
Simple Test Predicts Liver Disease: CORE Model Uses Three Blood Tests
What is the CORE model? A new risk-prediction tool called CORE has been developed to help primary care. It uses information from three simple blood tests that are already collected in routine checkups to estimate a patient’s ten-year risk of developing serious liver problems, including cirrhosis, liver cancer, or the need for a liver transplant.…
-
CORE Model Uses Three Blood Tests to Predict Liver Disease Risk
What is the CORE model and why it matters Liver disease is on the rise, and outcomes worsen when it is detected late. A new tool, known as the CORE model, has been developed to help primary care clinicians assess a patient’s risk of severe liver conditions before symptoms appear. By relying on three simple…
-
New Blood Test Reveals Future Risk of Severe Liver Disease
Researchers at Karolinska Institutet in Sweden have developed a simple blood test that can predict the risk of developing a severe liver disease within ten years. The test, designed for use in primary care, could help catch cirrhosis and liver cancer long before symptoms appear. What is the new liver disease risk test? The method…
-
New liver disease risk test could predict severe disease in a decade
Overview A new blood-based method developed at Karolinska Institutet offers a way to predict the risk of developing severe liver disease within ten years. The simple blood analysis is designed for use in primary care to identify individuals who are at higher risk of progressing to conditions such as cirrhosis or liver cancer. If validated…
-
New Blood Test Could Predict Severe Liver Disease in 10 Years
Overview Researchers at Karolinska Institutet have developed a simple blood analysis that may predict the risk of developing a serious liver disease within ten years. The test is designed for use in primary care, with the goal of spotting people at high risk for cirrhosis and liver cancer before symptoms appear. In initial studies, the…
-
Rising Fatty Liver Cases (+15%): Tests, AI Tools, and MasLD Insights
Rising fatty liver cases: what MasLD means for health Recent expert discussions highlight a worrying rise in fatty liver disease. Known as Metabolic dysfunction-associated steatotic liver disease (MasLD), this condition now affects a large share of adults worldwide and is increasingly recognized as a major public health challenge. MasLD describes the abnormal buildup of fat…
-
Fatty Liver Surge (+15%): Tests, Monitoring, and the Role of AI
What is MASLD and why are cases rising? Global health experts are sounding the alarm over a sharp rise in fatty liver disease, now often referred to as MASLD (Metabolic dysfunction-associated steatotic liver disease). Recent estimates place the condition in roughly 38% of the adult population worldwide, representing a 15% increase compared with two decades…